NCT07668674

Brief Summary

Some people with knee osteoarthritis (gonarthrosis) experience pain differently. In some, the pain is described as "nociceptive" (directly related to the joint), while in others it has "neuropathic" characteristics (related to nerve function). The goal of this multicenter, cross-sectional and comparative study is to compare resting brain activity in a brain region called the anterior insula among female patients with painful knee osteoarthritis who experience nociceptive pain compared to those with neuropathic pain. Researchers will compare brain activity at rest between these two types of pain in women over 40 with painful knee osteoarthritis. A better understanding could help improve pain management in the future. Participants will be asked to :

  • complete questionnaires during the inclusion visit and on the day of the scan,
  • undergo a clinical examination and a blood test at the inclusion visit,
  • undergo a functional MRI (fMRI), an imaging test that allows observation of brain activity at rest. Paticipants in the study does not involve any additional treatment. the fMRI scan is non-invasive and does not require any injections.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
24mo left

Started Jul 2026

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Jul 2026Aug 2028

First Submitted

Initial submission to the registry

April 24, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

June 25, 2026

Status Verified

April 1, 2026

Enrollment Period

2.1 years

First QC Date

April 24, 2026

Last Update Submit

June 23, 2026

Conditions

Keywords

GonarthrosisNeuropathic painNociceptive PainFunctional MRIAnterior insulaBrain activity in the anterior insula at restINDIGO

Outcome Measures

Primary Outcomes (1)

  • Resting-state anterior insula activity measured by functional MRI (BOLD signal amplitude)

    Comparison of resting-state anterior insula brain activity between patients with painful knee osteoarthritis with nociceptive pain and those with neuropathic-like pain, classified using the painDETECT questionnaire.

    At Visit 2 : within 30 days after inclusion, following Visit 1

Secondary Outcomes (3)

  • Functional connectivity of the anterior insula with pain-related brain regions (resting-state MRI)

    At Visit 2 : within 30 days after inclusion

  • Correlation between clinical pain scores ans anterior insula activity (resting-state fMRI)

    Clinical measures at Visit 1 and imaging measures at Visit 2 (within 30 days after inclusion)

  • Correlation between clinical pain scores ans anterior insula functional connectivity (resting-state fMRI)

    Clinical measures at visit 1 ; imaging at visit 2 (within 30 days after inclusion)

Other Outcomes (1)

  • Patient clusters identified using multimodal analysis including functional MRI and clinical data

    Data collected at Visit 1 and Visit 2 (within 30 days after inclusion)

Study Arms (2)

Nociceptive pain knee osteroarthritis

OTHER

Participants with painful knee osteoarthritis classified as having nociceptive pain based on PainDETECT questionnaire score ≤12.

Biological: blood samplingProcedure: Resting-state functional MRI

Neuropathic-like pain knee osteoarthritis

OTHER

Participants with painful knee osteoarthritis classified as having neuropathic-like pain based on PainDETECT questionnaire score \>13.

Biological: blood samplingProcedure: Resting-state functional MRI

Interventions

blood samplingBIOLOGICAL

Blood sampling will be performed at the inclusion visit. A biological assessment will include high sensitivity C reactive protein (hs-CRP) and metabolic markers (lipid profile, HbA1c, and fasting glucose). Additional blood samples (4 tubes) will be collected for biobank, including plasma and serum storage for the measurement of inflammatory markers.

Neuropathic-like pain knee osteoarthritisNociceptive pain knee osteroarthritis

Resting-state functional brain MRI will be performed at Visit 2 (within 30 days of the screening visit). Participants will undergo a brain MRI acquisition at rest to evaluate anterior insula activity and functional connectivity with pain-related brain regions.

Neuropathic-like pain knee osteoarthritisNociceptive pain knee osteroarthritis

Eligibility Criteria

Age40 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 40 or older (only women will be included to ensure consistency in the analyses, given the higher prevalence of osteoarthritis in women and the influence of sex/gender on the experience of pain)
  • Diagnosis of femorotibial osteoarthritis of the knee according to the 1986 American College of Rheumatology criteria
  • Presence of knee pain with an intensity of ≥ 4/10 on a numerical rating scale (NRS)
  • Chronic knee pain, i.e., lasting at least 6 months with at least 15 days of pain in the past 30 days
  • Completion of the PainDETECT questionnaire, which will allow the patient to be assigned to one of two groups prior to the enrollment visit (those with nociceptive pain \[score ≤ 12\] and those with neuropathic pain \[score \> 13\])
  • Patients have read and understood the information letter
  • Patients have signed the informed consent form
  • Patients are enrolled in a social security program

You may not qualify if:

  • Other joint diseases affecting the knees (gout, chondrocalcinosis, rheumatoid arthritis, spondyloarthritis, psoriatic arthritis)
  • Conditions that, in the investigator's opinion, interfere with the assessment of osteoarthritic pain, such as conditions causing neuropathic pain in the lower extremities (e.g., peripheral neuropathy, chronic radiculopathy) or fibromyalgia
  • Kellgren-Lawrence radiographic stage IV in one or both knees
  • Patients with one or more knee prostheses
  • Claustrophobia making MRI impossible
  • Contraindication to MRI
  • Pregnant or breastfeeding women
  • Patients under guardianship, conservatorship, deprived of liberty, or under judicial protection
  • Patients who have participated in an interventional clinical trial within the last 6 months that could impact the primary endpoint

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

CHU Clermont-Ferrand

Clermont-Ferrand, France

Location

APHP - Pitié-Salpêtrière

Paris, France

Location

APHP - Saint-Antoine

Paris, France

Location

MeSH Terms

Conditions

Osteoarthritis, KneeNeuralgiaNociceptive Pain

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Sylvain MATHIEU

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2026

First Posted

June 25, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

June 25, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations